The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study
Open accessAbstract
Purpose: Adjuvant chemotherapy improves patient survival rates after resection for pancreatic adenocarcinoma, but the optimal duration and time to initiate chemotherapy is unknown. Patients and Methods: Patients with pancreatic ductal adenocarcinoma treated within the international, phase III, European Study Group for Pancreatic Cancer–3 (version 2) study were included if they had been randomly assigned to chemotherapy. Overall survival analysis was performed on an intention-to-treat basis, retaining patients in their randomized groups, and adjusting the overall treatment effect by known prognostic variables as well as the start time of chemotherapy. Results: There were 985 patients, of whom 486 (49%) received gemcitabine and 499 (51%) received fluorouracil; 675 patients (68%) completed all six cycles of chemotherapy (full course) and 293 patients (30%) completed one to five cycles. Lymph node involvement, resection margins status, tumor differentiation, and completion of therapy were all shown by multivariable Cox regression to be independent survival factors. Overall survival favored patients who completed the full six courses of treatment versus those who did not (hazard ratio [HR], 0.516; 95% CI, 0.443 to 0.601; P < .001). Time to starting chemotherapy did not influence overall survival rates for the full study population (HR, 0.985; 95% CI, 0.956 to 1.015). Chemotherapy start time was an important survival factor only for the subgroup of patients who did not complete therapy, in favor of later treatment (P < .001). Conclusion: Completion of all six cycles of planned adjuvant chemotherapy rather than early initiation was an independent prognostic factor after resection for pancreatic adenocarcinoma. There seems to be no difference in outcome if chemotherapy is delayed up to 12 weeks, thus allowing adequate time for postoperative recovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Multimodel Inference: Understanding AIC and BIC in Model Selection
Burnham, K. P., & Anderson, D. R. (2004) · Sociological Methods & Research · doi:10.1177/0049124104268644 · Cited by 11,648 · cited 1×
“25.(20) Initial exploratory analyses showed that the time to the start of treatment had a different effect depending on whether or not a patient completed therapy, which was therefore included as a nested effect.”
BackgroundAsymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
Neoptolemos, J. P., Stocken, D. D., Friess, H., Bassi, C., Dunn, J. A., Hickey, H., Beger, H., Fernandez-Cruz, L., Dervenis, C., Lacaine, F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032295 · Cited by 2,716
Self-citationMetastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., Schramm, H., Fahlke, J., Zuelke, C., Burkart, C., et al. (2007) · JAMA · doi:10.1001/jama.297.3.267 · Cited by 2,419
Neoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M. J., Gallinger, S., Mariette, C., et al. (2010) · JAMA · doi:10.1001/jama.2010.1275 · Cited by 1,397
Self-citationNeoptolemos, J., Dunn, J., Stocken, D., Almond, J., Link, K., Beger, H., Bassi, C., Falconi, M., Pederzoli, P., Dervenis, C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06651-x · Cited by 1,111
Self-citationAnalysis of survival by tumor response.
Anderson, J. R., Cain, K. C., & Gelber, R. D. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.11.710 · Cited by 1,107
Martingale-based residuals for survival models
THERNEAU, T. M., GRAMBSCH, P. M., & FLEMING, T. R. (1990) · Biometrika · doi:10.1093/biomet/77.1.147 · Cited by 1,099
Analysis of survival by tumor response.
Anderson, J. R., & Davis, R. B. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.1.115 · Cited by 1,000
Regine, W. F., Winter, K. A., Abrams, R. A., Safran, H., Hoffman, J. P., Konski, A., Benson, A. B., Macdonald, J. S., Kudrimoti, M. R., Fromm, M. L., et al. (2008) · JAMA · doi:10.1001/jama.299.9.1019 · Cited by 755
Ueno, H., Kosuge, T., Matsuyama, Y., Yamamoto, J., Nakao, A., Egawa, S., Doi, R., Monden, M., Hatori, T., Tanaka, M., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605256 · Cited by 439
Haeno, H., Gonen, M., Davis, M. B., Herman, J. M., Iacobuzio-Donahue, C. A., & Michor, F. (2012) · Cell · doi:10.1016/j.cell.2011.11.060 · Cited by 409
Bakkevold, K. E., Arnesjø, B., Dahl, O., & Kambestad, B. (1993) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80349-1 · Cited by 338
Smeenk, H. G., van Eijck, C. H. J., Hop, W. C., Erdmann, J., Tran, K. C. K., Debois, M., van Cutsem, E., van Dekken, H., Klinkenbijl, J. H., & Jeekel, J. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318156eef3 · Cited by 321
Pancreatic Adenocarcinoma, Version 2.2012: Featured Updates to the NCCN Guidelines
Tempero, M. A., Arnoletti, J. P., Behrman, S. W., Ben-Josef, E., Benson, A. B., Casper, E. S., Cohen, S. J., Czito, B., Ellenhorn, J. D. I., Hawkins, W. G., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0073 · Cited by 304
Nowak, A. K., Robinson, B. W. S., & Lake, R. (2002) · PubMed · Cited by 238
Self-citationPancreatic Stellate Cells Radioprotect Pancreatic Cancer Cells through β1-Integrin Signaling
Mantoni, T. S., Lunardi, S., Al-Assar, O., Masamune, A., & Brunner, T. B. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1633 · Cited by 206
Understanding Metastasis in Pancreatic Cancer: A Call for New Clinical Approaches
Tuveson, D. A., & Neoptolemos, J. P. (2012) · Cell · doi:10.1016/j.cell.2011.12.021 · Cited by 188
Self-citationSeth, R., Tai, L., Falls, T. J., de Souza, C. T., Bell, J. C., Carrier, M., Atkins, H. L., Boushey, R. P., & Auer, R. C. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31826fcbdb · Cited by 135
Hata, S., Sakamoto, Y., Yamamoto, Y., Nara, S., Esaki, M., Shimada, K., & Kosuge, T. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2020-9 · Cited by 109
Suzuki, D., Furukawa, K., Kimura, F., Shimizu, H., Yoshidome, H., Ohtsuka, M., Kato, A., Yoshitomi, H., & Miyazaki, M. (2010) · Surgery · doi:10.1016/j.surg.2010.01.017 · Cited by 93
Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
Barton, J. G., Bois, J. P., Sarr, M. G., Wood, C. M., Qin, R., Thomsen, K. M., Kendrick, M. L., & Farnell, M. B. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-0849-z · Cited by 93
Ziprin, P., Ridgway, P. F., Pfistermüller, K. L. M., Peck, D. H., & Darzi, A. W. (2003) · Cell Communication & Adhesion · doi:10.1080/15419060390262561 · Cited by 84
Laethem, J. V., Verslype, C., Iovanna, J., Michl, P., Conroy, T., Louvet, C., Hammel, P. R., Mitry, E., Ducreux, M. P., Maraculla, T., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr351 · Cited by 82
Self-citationSmith, R. A., Bosonnet, L., Ghaneh, P., Raraty, M. G. T., Sutton, R., Campbell, F., & Neoptolemos, J. P. (2008) · Digestive Surgery · doi:10.1159/000140961 · Cited by 78
Self-citationBassi, C., Stocken, D. D., Oláh, A., Frieß, H., Buckels, J. A. C., Hickey, H., Dervenis, C., Dunn, J., Deakin, M., Carter, R., et al. (2005) · Digestive Surgery · doi:10.1159/000089771 · Cited by 74
Self-citationZiprin, P., Ridgway, P. F., Pfistermüller, K. L. M., Peck, D. H., & Darzi, A. W. (2004) · PubMed · Cited by 66
Fukutomi, A., Uesaka, K., Boku, N., Kanemoto, H., Konishi, M., Matsumoto, I., Kaneoka, Y., Shimizu, Y., Nakamori, S., Sakamoto, H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.4008 · Cited by 51
Bellone (2009) · International Journal of Oncology · doi:10.3892/ijo_00000301 · Cited by 49
Hallemeier, C. L., Botros, M. E., Corsini, M. M., Haddock, M. G., Gunderson, L. L., & Miller, R. C. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181f946fc · Cited by 47
Watson, K. (1976) · PubMed · Cited by 47
Pueyo, G., Mesı́a, R., Figueras, A., Lozano, A., Baro, M., Vázquez, S., Capellá, G., & Balart, J. (2010) · The Oncologist · doi:10.1634/theoncologist.2008-0290 · Cited by 36
Cited by
Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M., Faluyi, O., O'Reilly, D. A., Cunningham, D., Wadsley, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32409-6 · Cited by 1,926
Self-citationPersonalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Rojas, L. A., Sethna, Z., Soares, K. C., Olcese, C., Pang, N., Patterson, E., Lihm, J., Ceglia, N., Guasp, P., Chu, A., et al. (2023) · Nature · doi:10.1038/s41586-023-06063-y · Cited by 1,432
Therapeutic developments in pancreatic cancer: current and future perspectives
Neoptolemos, J. P., Kleeff, J., Michl, P., Costello, E., Greenhalf, W., & Palmer, D. H. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0005-x · Cited by 1,170
Self-citationOptimizing the outcomes of pancreatic cancer surgery
Strobel, O., Neoptolemos, J., Jäger, D., & Büchler, M. W. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0112-1 · Cited by 943
Self-citationPancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Conroy, T., Pfeiffer, P., Vilgrain, V., Lamarca, A., Seufferlein, T., O’Reilly, E. M., Hackert, T., Golan, T., Prager, G., Haustermans, K., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2023.08.009 · Cited by 610
Metadata
- Authors
- Valle, J. W., Palmer, D., Jackson, R., Cox, T., Neoptolemos, J. P., Ghaneh, P., Rawcliffe, C. L., Bassi, C., Stocken, D. D., Cunningham, D., O'Reilly, D., Goldstein, D., Robinson, B. A., Karapetis, C., Scarfe, A., Lacaine, F., Sand, J., Izbicki, J. R., Mayerle, J., Dervenis, C., Oláh, A., Butturini, G., Lind, P. A., Middleton, M. R., Anthoney, A., Sumpter, K., Carter, R., & Büchler, M. W.
- Venue
- Journal of Clinical Oncology
- Published
- 2014-02-20
- Volume
- 32
- Issue
- 6
- Pages
- 504-512
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2129884672
- Cited by
- 455
- References
- 39
- FWCI
- 18.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.